Black Rock Inc. 2seventy Bio, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TSVT
# of Institutions
15Shares Held
4.88MCall Options Held
0Put Options Held
0-
Chi Advisors LLC New York, NY1MShares$5.01 Million1.94% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL104KShares$518,2400.0% of portfolio
-
Colony Group LLC Boston, MA53.3KShares$266,3750.0% of portfolio
-
Ajo Vista, LLC Boston, MA20.3KShares$101,2750.42% of portfolio
-
Quantamental Technologies LLC White Plains, NY19.1KShares$95,5450.07% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $189M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...